CTD dossier format and preparation checklist for pharma teams
A CTD dossier organises a pharmaceutical application into five modules. See what each module holds, how to prepare one and how ASEAN ACTD differs.
CTD dossier format and how to prepare one
A CTD dossier is a pharmaceutical application organised into the five modules of the ICH Common Technical Document format (ICH M4 overview). To prepare one, confirm the receiving authority and pathway, organise the applicable evidence, reconcile summaries, assemble regional documents and check electronic requirements.
In pharma regulatory affairs, a dossier is the set of documents submitted to a regulator to support an application. M4 primarily addresses how that information is organised in registration applications for new pharmaceuticals, including biotechnology-derived products (ICH). The structure does not itself determine which studies an application needs. Determine those requirements for the product, pathway and receiving authority.
What goes in a CTD dossier
ICH guideline M4 covers the organisation of the CTD for human medicines. Module 1 is region specific. Modules 2 to 5 are intended to be common across regions (ICH). "Intended to be common" is a design goal. It does not mean one unchanged dossier is accepted everywhere.
| Module | What it holds |
|---|---|
| 1 | Regional administrative information and prescribing information |
| 2 | CTD summaries and overviews |
| 3 | Quality information |
| 4 | Nonclinical study reports |
| 5 | Clinical study reports |
Source: ICH CTD page. For a PDF reference to the CTD dossier format, use the official M4(R4) organisation guideline. It describes the structure, not a completed dossier template.
Module 2 needs more care than its "summaries" label suggests. ICH lists a general introduction (pharmacological class, mode of action and proposed clinical use), the Quality Overall Summary, the Nonclinical Overview, the Clinical Overview, the nonclinical written summaries and tabulated summaries, and the Clinical Summary (ICH). These documents do different jobs. The Nonclinical Overview critically assesses pharmacology, pharmacokinetics and toxicology. The Clinical Overview is also a critical assessment. The Clinical Summary summarises and integrates the clinical data.
Module 3 carries the chemistry, manufacturing and controls (CMC) evidence. M4Q gives a harmonised structure, with separate drug substance, drug product and pharmaceutical development sections. The quality information covers biological and biotechnological products as well as chemical ones (ICH).
How to prepare a CTD dossier
This CTD dossier checklist is project advice based on the CTD structure. It is not an ICH-mandated sequence or a guarantee of acceptance or approval.
- Fix the destination first. Confirm the receiving authority, product category and application pathway. These decide which evidence and which regional documents you need.
- Map what you have against the structure. Place each existing report and data set under its CTD heading. Judge gaps against the authority's actual requirements, not the headings alone.
- Assign owners. Give named people responsibility for quality, nonclinical, clinical, administrative and summary documents. Module 2 authors need early access to Modules 3 to 5.
- Write the technical sections, then reconcile the summaries. M4Q says the Quality Overall Summary should not introduce information, data or justification that is absent from the rest of the CTD (M4Q(R1)). For the other Module 2 documents, check consistency with the supporting evidence while preserving each document's purpose. Overviews need critical assessment, not just repetition. Check substance and product names, strengths and other repeated details for consistency.
- Build Module 1 for this market. Get the authority's current forms and its prescribing and labelling requirements. Don't copy another region's Module 1 unchanged.
- Check electronic conformance as a separate task. Arranging documents under CTD headings is not the same as producing a valid electronic submission. The FDA, for example, describes eCTD as the standard format for applications, amendments, supplements and reports to CDER and CBER. Its eCTD page also publishes regional Module 1 standards, technical conformance guides and submission resources. A folder of PDFs named after CTD sections is not a validated eCTD.
- Keep dossier preparation and submission separate. Review scientific completeness and technical conformance, and fix both before you file.
For UK and Indian submissions, check the MHRA's or CDSCO's current guidance for your specific pathway before you settle the format and electronic requirements.
CTD vs ACTD for ASEAN markets
The ASEAN Common Technical Dossier (ACTD) holds the same kinds of information in four parts instead of five modules. The main difference is where the summaries sit. ACTD has no standalone Module 2. It places the overviews and summaries inside the technical parts. Singapore's Health Sciences Authority (HSA) maps the two formats like this (HSA application dossier):
| ICH CTD | ACTD |
|---|---|
| Module 1, administrative documents | Part I |
| Module 2, overviews and summaries | Incorporated in Parts II, III and IV |
| Module 3, quality documents | Part II |
| Module 4, nonclinical documents | Part III |
| Module 5, clinical documents | Part IV |
For a therapeutic product, HSA requires the application dossier to be organised in either ICH CTD or ACTD format, with non-eCTD and eCTD options for ICH CTD (HSA application dossier). That is Singapore's rule. It is not evidence of identical format rules throughout ASEAN. Check the receiving authority before you choose a format.
Common mistakes in dossier preparation
- Treating format compliance as proof of adequate evidence. A dossier can fit every heading and still lack the data an assessor needs.
- Treating the Quality Overall Summary, an overview and the Clinical Summary as interchangeable.
- Reusing one region's Module 1 numbering or administrative rules in another market.
- Assuming CTD and eCTD mean the same thing.
- Assuming every ASEAN authority follows the same policy as Singapore.
RegAffairs AI answered "How do I prepare a CTD dossier?", with citations to the ICH M4 guidelines, on this public answer page.